Monday October 26th


Tom Maniatis, PhD

Evnin Family Scientific Director and CEO, ​New York Genome Center Professor, ​Zuckerman Institute, Columbia University

2:00 pm - 2:30 pm

Eric Vivier, DVM, PhD

Professor in Immunology, Centre d’Immunologie de Marseille-Luminy, Hôpitaux Universitaires de Marseille; ​Chief Scientific Officer, ​Innate-Pharma “Association of the C5a-C5aR1 axis with COVID-19 inflammation”

2:30 pm - 3:00 pm

Erich Jarvis, PhD

Professor, ​The Rockefeller University; ​Investigator, ​Howard Hughes Medical Institute

​”Generating high-quality genomes of species that are vulnerable and resistant to COVID-19”

3:00 pm - 3:30 pm

James M Musser, MD, PhD

Fondren Distinguished Endowed Chair; Chair, Department of Pathology and Genomic Medicine, H​ouston​ ​Methodist Hospital; ​Director, ​Center for Molecular and Translational, Human Infectious Diseases Research,
Houston Methodist Research Institute; ​Professor of Pathology and Laboratory Medicine, W​eill Cornell Medical College of Cornell University

“Recent discoveries and lessons learned from a seven-month integrated study of SARS-CoV-2 and COVID-19, Houston, Texas”

3:30 pm - 4:00 pm

   Mitch Guttman, PhD

Professor of Biology, Division of Biology and Biological Engineering, ​California Institute of Technology​; Robertson Investigator, ​New York Stem Cell Foundation; ​Investigator, ​Heritage Medical Research Institute

“​SARS-CoV-2 disrupts mRNA splicing, translation, and protein trafficking to suppress host defenses”